According to a new report Europe Intragastric Balloon Market, published by KBV research, the Europe Intragastric Balloon Market would witness market growth of 12% CAGR during the forecast period (2020-2026).
The Germany market is one of the major revenue generating regions within the Europe Dual Market by Country in 2019, growing at a CAGR of 12.5 % during the forecast period. The UK market is witnessing a CAGR of 12.2% during (2020 - 2026). Additionally, The France market is projected to grow at a CAGR of 14.7% during (2020 - 2026).
The Hospitals market dominated the France Intragastric Balloon Market by End-use in 2019, growing at a CAGR of 12.9 % during the forecast period. The Clinics market is experiencing a CAGR of 13.6% during (2020 - 2026). The Ambulatory Surgical Centers market would showcase a CAGR of 14.3% during (2020 - 2026).
The Endoscopy market dominated the Spain Intragastric Balloon Market by Administration in 2019, thereby, achieving a market value of $1125.5 Thousands by 2026, growing at a CAGR of 12.1 % during the forecast period. The Pill Form market is expected to witness a CAGR of 15.2% during (2020 - 2026).
Structural Insights: https://www.kbvresearch.com/europe-intragastric-balloon-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Sientra, Inc. (Silimed, Inc.), Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., ReShape Lifesciences Inc., Allurion Technologies, Inc., Helioscopie SA (Sante Actions Group), Districlass Medical SA, Spatz FGIA, Inc., Duomed Group (Life Partners Europe), Medsil.
By Administration
By Type
By Filling Material
By End Use
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
